NVAX
NVAX UP 13%NVAX is HOT right now.
Earlier yesterday I expected a pullback, but there is no way of telling when the buy craze will end.
What I'm monitoring from the chart:
Momentum, to indicate a possible trend reversal - for now the momentum is still HOT
RSI, also to monitor momentum and buy power - right now the buyers are in firm control
Bollinger Bands, to monitor the volatility and overbought / oversold area - we have been running overbought for days
So at this point, NVAX is going incredibly strong but I am keeping an eye out for a possible sell off or minor correction to enter again with a lower position.
Hit like if you found this helpful
Thanks, E
NVAX SWING TRADEI just closed a trade with 15% profit in NVAX after the recent bull run.
I believe you should not be too greedy when it comes to taking profit.
I predict a small selloff will cause a minor correction, we might see a return to $100 since there are strong selling indicators.
And then a buying opportunity is present.
Hit like if you found this helpful or interesting, thanks !
Regards, E
CREATIVE WAYSAccording to source, Pinterest has recently seen the highest searches ever around mental wellness ideas including meditation (+44%), gratitude (+60%) and positivity (+42%) that jumped from February to May. Pinners are looking for creative ways to navigate and cope with their “new normal,” so they took a closer look at their shifting priorities to understand which trends would live out the remainder of 2020.
[NVAX] Novavax: Preliminary studies produce promising resultsPreliminary studies on coronavirus vaccines have produced promising results.
I'm still a believer in their technology. Check out my previous NVAX posts and/or the first one. They have a promising technology that could revolutionize the vaccine industry. We (humanity) are already very behind in how we produce vaccines AKA using chicken eggs. So Novavax will hopefully pave the way for vaccines going forward.
Things to watch even after COVID-19:
- NanoFlu™
- ResVax™
- Recombinant Nanoparticle Vaccine Technology
- Matrix-M™ Adjuvant Technolog
TL;DR - To the moon and (probably) back lol
*Note: This is pure speculation and my own opinion*
NY Times: www.nytimes.com
CNBC: www.cnbc.com
NVAX'S VACCINE FOR FLU IS PROMISING! Hello traders!
Good news from Novavax! The chances of approval for flu vaccine candidate NanoFlu seems actually quite good!
Moreover, if we look at the chart, we can see that the price is on a strong uptrend that doesn't seem to want to stop. The bullish momentum is still strong!
Remember to put a stop loss in order to secure your capital!
Not a financial advice.
Enjoy your trade!
Chalice Golde Mines Major Breakout $CHNChalice Golde Mines Major Breakout of 10 year base. The bigger the base the higher in space. Three district scale exploration properties in the best and most prolific areas in Australia. Tier one assets. Exploring near some of the most profitable mines in the world including the Fosterville Gold Mine owned by Kirkland Lake Gold (NYSE / TSX: KL | ASX: KLA) and 22Moz @ 15g/t Au Bendigo Goldfield.
NVAX: Key Points to Look AtEarlier today, I put a target of at most $115 and later was convinced to do a sell off at $108. Many people thought this would go straight to $150+, but it looks like the positive wedge have peaked. Right now, I currently think the dip will likely be at the $90 price point, but an important factor to consider is closely monitoring movement at the $95 mark. The advanced decline ratio seems to be peaking, and the FIB retracement also showed that it was towards its high point in the morning for the current correlation trend. As always, invest in your own risk and proceed with caution. This is on an opinion based basis.
[NVAX] Novavax: Update - 1.6 billion funded!I still believe NVAX has a lot of potential and I'll say it again. My idea is clear that its NanoParticle and Matrix-M Adjuvant tech makes it a prime candidate for a COVID-19 vaccines. Even if it doesn't make it first (or ever), it still has major potential for the seasonal influenza (w/ NanoFlu) and its Respiratory Syncytial Virus (RSV) vaccine. Check out my original post that is linked.
Today's News:
1. www.cnbc.com
2. www.fool.com
Wall Street is Short VBIV, but I'm Long *Target: [$3.50]*Link to Culper Research report that states they are shorting VBIV because the company is "worthless"
img1.wsimg.com
First, it's always important to consider ALL information. It's also important to be transparent about knowledge. If you are going to make any VBIV trades you really should read the entire report.
1) I think many of the points made in the Culper Report are legitimate
2) I am not as optimistic about long term price targets as those seen at Guggenheim and on yahoo finance
3) I still believe this is a good short-term trade based on sentiment and momentum regarding June 22-24 release of clinical glioblastoma data
Stop loss @ $2.04
NVAX Long - $150 Target?I've been following NVAX since price was at $12. Fundamentally they have one of the most promising COVID vaccines and their Nano Flu shot beat Sanify's flu shot, whos been a market majority holder in that aspect.
Technically, we've tapped that $150+ zone 8 out of the last 9 fast rises over since the company IPO'd in 1996. Each of the rises have been driven by pandemic viruses..ie, swine flu, bird flu, H1N1, etc.
We have 4 days until the quarterly candle closes. If we close strong, we'd of closed above the coral, and momentum and RSI are correlating. I think we will see a short term sell off at the psychological $100 level. How much? I could see $80-$85 be a good rebuy zone to push price up to t $125 then $150. Buyers at $80, will probably be looking for a double on their investment which would put price at $160.
Let me know what you think!
Novavax (NVAX) stock price is on track...for now [LONG]Just re-iterating my previous assertion (guess) that NVAX is on course for massive gains in the long-term. Doesn't mean it's a great company but this pandemic has initiated a similar pattern in the past. They have several great developments in the works: NanoFlu, RSV F, and a COVID-19 vaccine candidate. See my previous posts especially the related one.
This is purely speculation based on their pipeline. This is not financial advice.